Virtu Financial’s Atrium Therapeutics RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$93K Buy
+11,280
New +$133K ﹤0.01% 1186

Other funds holding RNA

Virtu Financial's RNA Position: Q3 2026 in Review

Virtu Financial opened a new position in Atrium Therapeutics (RNA) in Q3 2026: 11,280 shares worth $93K. The stake represents ﹤0.01% of the portfolio and ranks #1186 among its holdings.

148 funds tracked by Wall St. Rank hold RNA as of Q3 2026.

  • Virtu Financial held 11,280 shares of Atrium Therapeutics worth $93K as of Q3 2026.
  • Atrium Therapeutics was a new Virtu Financial position in Q3 2026.
  • Atrium Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q3 2026, its #1186 holding.
  • 148 funds tracked by Wall St. Rank held Atrium Therapeutics as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.